Page 99 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

Box 3.6

General Outpatient Clinic Public Private Partnership
Programme (GOPC-PPP) Fact Sheet

Launched: Mid-2014

Objectives:
(a) Provide choice to patients for receiving primary care service from the
private sector in their community;
(b) Enhance patient access to primary care service;
(c) Promote the family doctor concept;
(d) Help HA manage demand for general/specialist outpatient service; and
(e) Foster the development of the territory-wide Electronic Health Record
Sharing System (eHRSS).

Eligibility:

Patients fulfilling pre-defined clinical criteria (with hypertension and/or
diabetes mellitus (DM), with or without hyperlipidemia, and are deemed
clinically stable) and programme requirements. Patients who have been
attending HA GOPC for at least 12 months will be invited to join the
programme to receive primary care service from the private sector.

Services for each person:
(a) Up to 10 subsidised consultations each year (at the same GOPC price of
HKD 50 per visit), including medical consultations for both chronic and
episodic illness;
(b) Drugs for treating their chronic conditions and episodic illnesses from the
private doctors at their clinics immediately after each consultation; and
(c) Relevant laboratory and x-ray services provided by HA upon referral by
the participating private doctors.

Incentives for provider:
Participating private doctors receive a maximum total payment of HKD 3,510
per patient per year (on a reimbursement basis), which includes the GOPC
fee of HKD 50 per consultation paid by patients

Key progress:
• The Programme has now been implemented in all 18 districts of
Hong Kong, and nearly 600 private doctors have participated in the
Programme.
• More than 40,000 patients have participated in the programme, and more
than 680,000 consultations were provided as of the end of June 2021.
• An interim review was undertaken by the HA in 2016.
• A Co-Care service model is introduced in the third quarter of 2021 in
which eligibility to this programme is expanded to patients at selected HA
SOPCs with stable clinical conditions.

Sources: HA, 2021b, 2021c; HKSARG, 2021c

97